Hypomethylation of DNA, which can be achieved by incorporation of 5-azacytidine, has been correlated with derepression of genes. In order to examine the in vivo effects of 5-azacytidine on organ development and differentiation, young rats were treated with the drug. There was an almost complete reduction of thymus and a marked reduction of spleen weight, while other organs, including testes were only marginally affected. Control experiments with cytosine-arabinoside suggest that treatment with an inhibitor of DNA replication per se is not responsible for the very rapid thymus involution triggered by 5-azacytidine in rats. In spite of the drastic reduction of thymus and spleen weight, lymphocytes of these organs were not impaired in their response to the T cell mitogen Concanavalin A.
Skip Nav Destination
Article navigation
Rapid Communication|
July 01 1986
Thymus involution induced by 5-azacytidine
Adam Csordas;
Adam Csordas
1Institute of Medical Chemistry and Biochemistry, University of Innsbruck, A-6020 Innsbruck, Fritz-Pregl Str. 3, Austria
Search for other works by this author on:
Konrad Schauenstein
Konrad Schauenstein
2Institute for General and Experimental Pathology, University of Innsbruck, A-6020 Innsbruck, Fritz-Pregl Str. 3, Austria
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
June 26 1986
Online ISSN: 1573-4935
Print ISSN: 0144-8463
© 1986 Plenum Publishing Corporation
1986
Biosci Rep (1986) 6 (7): 603–612.
Article history
Received:
June 26 1986
Citation
Adam Csordas, Konrad Schauenstein; Thymus involution induced by 5-azacytidine. Biosci Rep 1 July 1986; 6 (7): 603–612. doi: https://doi.org/10.1007/BF01114754
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |